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Abstract This study aimed to evaluate the time course of
perioperative blood glucose levels of children undergoing
cardiac surgery for congenital heart disease in relation to
endogenous stress hormones, inﬂammatory mediators, and
exogenous factors such as caloric intake and glucocorticoid
use. The study prospectively included 49 children under-
going cardiac surgery. Blood glucose levels, hormonal
alterations, and inﬂammatory responses were investigated
before and at the end of surgery, then 12 and 24 h afterward.
In general, blood glucose levels were highest at the end of
surgery. Hyperglycemia, deﬁned as a glucose level higher
than 8.3 mmol/l ([150 mg/dl) was present in 52% of the
childrenattheendofsurgery. Spontaneousnormalizationof
blood glucose occurred in 94% of the children within 24 h.
During surgery, glucocorticoids were administered to 65%
of the children, and this was the main factor associated with
hyperglycemia at the end of surgery (determined by uni-
variate analysis of variance). Hyperglycemia disappeared
spontaneously without insulin therapy after 12–24 h for the
majority of the children. Postoperative morbidity was low in
the study group, so the presumed positive effects of gluco-
corticoids seemed to outweigh the adverse effects of iatro-
genic hyperglycemia.
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Glucocorticoids  Hyperglycemia  Insulin
Hyperglycemia is a regular phenomenon in critically ill
children after surgical repair or palliation of congenital
heart defects. Some recent studies have shown an associ-
ation of hyperglycemia with increased postoperative mor-
bidity and mortality in these children [7, 18, 35].
The adult literature contains a debate on the usefulness
of intensive insulin therapy for glucose control to improve
morbidity and mortality rates for cardiac surgical patients
[8, 13]. The only randomized controlled study of critically
ill children showed improved short-term outcome after
treatment with intensive insulin therapy targeting blood
glucose levels to age-adjusted normal fasting concentra-
tions [31], but debate exists on the harm of insulin-induced
hypoglycemic events [11].
For glucose control protocols to be most efﬁcient, they
should be based on pathophysiologic mechanisms [30].
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DOI 10.1007/s00246-010-9829-zSeveral studies have addressed this topic for critically ill
adults [15, 16, 26], but such studies of critically ill children
are lacking.
Hyperglycemia in critically ill children is caused by
multiple factors, among which endogenous stress hor-
mones [2], inﬂammatory mediators, oxidative stress, and
therapeutic interventions such as glucose and drug
administration are the main causative factors.
Children undergoing cardiopulmonary bypass (CPB)
surgery often receive perioperative glucocorticoids to
attenuate the systematic inﬂammatory response, but to
date, no clinical beneﬁt has been shown [22]. However,
hyperglycemia is a well-known side effect of glucocorti-
coid use. We hypothesized that in some settings, the
adverse effects of steroid-induced hyperglycemia could
outweigh the anticipated beneﬁts.
The current study aimed to evaluate blood glucose levels
in children undergoing open heart surgery relative to stress-
induced endogenous hormonal production, inﬂammatory
mediators, and exogenous factors such as caloric intake and
glucocorticoid use.
Materials and Methods
Patients
Eligible subjects were consecutive children with congenital
heart disease who had undergone open-heart surgery in the
Erasmus MC during a 2-year period. Children were not
eligible for the study if they had endocrine or chromosomal
abnormalities or had received radiation or chemotherapy
within the previous 6 months. The Erasmus MC Medical
Ethics Review Board approved the study (196.429/2000/
222), and written informed consent was obtained from the
parents or legal representatives of each child and of all
children older than 12 years.
Clinical Parameters
Anthropometric measurements were taken the day before
cardiac surgery. The children were fasted before and during
surgery and received glucose intravenously (4–6 mg/kg/
min) after surgery according to protocol. Enteral nutrition
was initiated on the ﬁrst postoperative day if clinically
possible.
Severity of illness was assessed by Risk Adjustment for
Congenital Heart Surgery (RACHS) [10], the pediatric risk
of mortality (PRISM) score [19], the pediatric logistic
organ dysfunction (PELOD) score [14], and levels of
established biomarkers such as interleukin-6 (IL-6), IL-10,
and arterial lactate.
Congestive heart failure was deﬁned by the criteria of
Van der Kuip et al. [27] adjusted for age. The presence of
cyanotic heart disease, the duration of CPB, and the aorta
cross-clamp time were recorded.
During cardiac surgery, most of the children received
mild hypothermia (median, 31C), and one child (age,
16.6 years) received deep hypothermia (22.5C). All the
children received standardized analgesia during and after
surgery. Glucocorticoids were administered at the discre-
tion of the attending anesthetist. The decision to administer
glucocorticoids was made before the start of surgery and
independently of the operative course. Standardized pro-
tocols were used for administration of inotropes and
weaning from the ventilator. The weighted inotropic (WI)
score based on maximum inotropic support during surgery
and intensive care unit (ICU) stay was calculated [33].
Duration of mechanical ventilation, presence of wound
infections, length of ICU and hospital stays, and survival
were recorded.
Collection of Blood and Assays
Arterial blood samples were obtained at the start of surgery
after induction of anesthesia, at the end of surgery after
sternal closure, and then 12 and 24 h afterward. All labo-
ratory parameters except cytokines were determined
immediately. Serum and plasma were stored at -80C
until assayed.
Glucose and lactate were determined on an ABL 725
blood gas analyser (Radiometer; Copenhagen, Denmark) in
a certiﬁed clinical chemistry laboratory (ISO 17025 and
9001). Hypoglycemia was deﬁned as a blood glucose level
of 2.2 mmol/l (B40 mg/dl) or lower and hyperglycemia as a
blood glucose level of 8.3 mmol/l ([150 mg/dl) or higher
[30]. The normal value for lactate was less than 2.0 mmol/l.
Serum insulin concentrations were determined with an
immunoradiometric assay on an Immulite 2000 (Diagnos-
tic Product Corporation, Los Angeles, CA, USA) with a
minimum detection level of 35 pmol/l [6]. In our labora-
tory, the maximum fasting reference value for insulin is
180 pmol/l. The insulin/glucose ratio was calculated to
assess insulin sensitivity. To date, no strict reference values
exist for the (non)-fasting glucose-to-insulin ratio. In our
study, the maximum reference value for the insulin–glu-
cose ratio was deﬁned as 18 pmol/mmol. We derived this
value from current literature data, taking into account the
differences between insulin assays and units of analysis
[5, 28, 32].
Serum cortisol concentrations were determined using an
Immulite 2000 competitive luminescence immunoassay
(DPC) with detection limits of 3–1,380 nmol/l. The normal
level of cortisol during stress was deﬁned as a cortisol level
higher than 496 nmol/l [17]. Plasma adrenocorticotrope
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123hormone (ACTH) concentrations were determined by an
immunoradiometric assay (Bio International, Gif sur
Yvette, France). The within- and between-assay variation
coefﬁcients for the assays of cortisol and ACTH were less
than 7%.
Plasma cytokine levels were analyzed with an enzyme-
linked immunosorbent assay (Sanquin, Amsterdam, The
Netherlands). The detection limit of IL-6 (lowest positive
standard) was 10 pg/ml, and that of IL-10 was 25 pg/ml.
Statistical Analysis
Data were analyzed with SPSS 16.0 (SPSS inc., Chicago,
IL, USA). The results are expressed as median (inter-
quartile range) unless speciﬁed otherwise. The Mann–
Whitney U test, the chi-square test, and Fisher’s exact test
were used for group comparison. Univariate analysis of
variance (ANOVA) was used to assess relationships
between glucose, steroid use, and disease severity as
expressed by WI score and CPB time. Data were log-
transformed when necessary. Two-tailed p values less than
0.05 were considered statistically signiﬁcant.
Results
Patient Characteristics
The study group consisted of 49 children (24 boys) ages
2 months to 18 years. The children had surgery for left–
right shunt patch closure of ventricular septal defect
(n = 13, including 6 children with combined closure of
atrial septal defect and 1 child with additional repair of the
tricuspid valve), closure of atrial septal defect (n = 7),
patch closure of the aortopulmonary window together with
reimplantation of anomalous left coronary artery from the
pulmonary artery (n = 1); corrective surgery for tetralogy
of Fallot (n = 9), univentricular heart (partial cavopul-
monary connection, n = 4; total cavopulmonary connec-
tion, n = 2), left ventricular outﬂow tract obstruction
(enucleation, n = 4; pulmonary autograft, n = 2; allograft
aortic root replacement, n = 2), right ventricular outﬂow
tract obstruction (infundibulectomy, n = 2; pulmonary
allograft, n = 1), and mitral valve insufﬁciency (mitral
valve annuloplasty, n = 2).
Clinical Parameters
All the children underwent elective cardiac surgery upon
CPB support, and 45 of the children underwent cardio-
plegic arrest. All survived.
At the end of surgery, 30 of the children were receiving
inotropic support, with 16 receiving dopamine, 6 receiving
dobutamine, 7 receiving both dopamine and dobutamine,
and 1 receiving noradrenalin.
Duringcardiacsurgery,32(65%)ofthechildrenreceived
one bolus of glucocorticoids. The bolus was received by 12
children after induction of anesthesia before surgical inci-
sion,8childrenatthestartofheparinizationbeforeCPB,and
12 children at aortic cross-clamping. All except two of the
children received methylprednisolone (30 mg/kg), with one
child receiving dexamethasone (1 mg/kg) and one child
receiving hydrocortisone (2 mg/kg).
For the purpose of this study, we created two groups:
those treated with glucocorticoids (n = 32) and those
treated without glucocorticoids (n =17). No wound infec-
tions occurred. None of the patients received insulin during
surgery or ICU stay. The clinical parameters are depicted
in Table 1.
Time Courses of Laboratory Parameters
Table 2 shows the laboratory results at the start of surgery,
at the end of surgery, and at 12 and 24 h after surgery for
the group as a whole.
Glucose
Table 2 shows the blood glucose levels from the start of
surgery up to 24 h after surgery. Hypoglycemia
(B2.2 mmol/l [B40 mg/dl]) did not occur. In general,
blood glucose levels were highest at the end of surgery.
At start of surgery, hyperglycemia ([8.3 mmol/l
[[150 mg/dl]) was present in one patient. At the end of
surgery, hyperglycemia was present in 52% (25/48) of the
children, decreasing to 11% (5/47) after 12 h and to 6%
(3/47) after 24 h. Thus, almost all the children were nor-
moglycemic after 24 h. Hyperglycemia was not associated
with ventilation days nor with the length of the ICU or
hospital stays.
Plasma Insulin and Insulin–Glucose Ratios
Table 2 shows the endogenous plasma insulin levels and
the insulin–glucose ratios from the start of surgery to 24 h
after surgery. At the start of surgery, the plasma levels of
insulin in all the children were below the maximum fasting
reference level. In all but one of the children (98%), the
insulin–glucose ratios were below the maximum reference
value.
At the end of surgery, the plasma levels of insulin in 6%
(3/48) of the children were above the maximum reference
level. The insulin–glucose ratio was increased more than
18 pmol/mmol in 9% (4/47) of the children. They had
blood glucose levels varying between 7.4 and 10.8 mmol/l.
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123Of the remaining children, with an insulin–glucose ratio of
18 pmol/mmol or less, 53% (23/43) had hyperglycemia.
At 12 h after surgery, none of the children had plasma
insulin levels or an insulin–glucose ratio above the maxi-
mum reference value. The insulin levels and insulin–glu-
cose ratios were highest 24 h after surgery. The plasma
insulin levels in 9% (4/46) of the children were above the
maximum reference level. The insulin–glucose ratio was
increased more than 18 pmol/mmol in 20% (9/46) of the
children, but only three of them were hyperglycemic. In the
remaining children, with an insulin–glucose ratio less than
18 pmol/mmol, hyperglycemia did not occur.
Inﬂuence of Glucocorticoids
During surgery, 65% (32/49) of the children were treated
with glucocorticoids. The clinical parameters before sur-
gery did not differ between the children with and those
without glucocorticoid treatment except for the prevalence
of cyanotic heart disease and the WI score, both of which
were signiﬁcantly higher in the children with steroid
treatment (Table 1). The laboratory results at the various
time points are shown in Table 2 and Fig. 1.
The blood glucose levels at the start of surgery, before
glucocorticoid treatment, did not differ between the groups
(Fig. 1a). At the end of surgery, the blood glucose levels in
the children treated with glucocorticoids were signiﬁcantly
higher than in those without glucocorticoid treatment.
Hyperglycemia occurred signiﬁcantly more often in the
group that had glucocorticoid treatment (p = 0.001).
The effect of glucocorticoid treatment on the blood
glucose levels at the end of surgery was independent of
other parameters such as glucose intake, presence of cya-
notic heart disease, WI score, and CPB time. At 12 and
24 h after surgery, the median blood glucose levels did not
differ between the groups. The insulin levels and insulin–
glucose ratios did not differ between the groups at any time
point (Fig. 1b, c).
The maximum peak cortisol levels were found at the end
of surgery, with signiﬁcantly higher cortisol levels and
Table 1 Clinical parameters
Variable Glucocorticoids (n = 32) No glucocorticoids (n = 17) All patients (n = 49)
Demographic data
Age: years (range) 1.4 (0.5–6.2) 3.2 (0.6–13.3) 1.7 (0.5–8.7)
Sex (F/M) 15/17 10/7 25/24
Weight: kg (range) 8.7 (6.6–18.2) 13.0 (6.3–42.0) 12.3 (6.6–24.4)
Body mass index: kg/m
2 (range) 14.8 (13.6–15.9) 15.1 (14.3–17.5) 14.9 (14.1–16.3)
Illness severity
Congestive heart failure: n (%) 11/32 (34) 3/17 (18) 14/49 (29)
Cyanotic heart disease: n (%) 10/32 (31)
a 1/17 (6) 11/49 (22)
RACHS score (range) 3 (2–3) 2 (1–3) 3 (2–3)
PRISM score (range) 14 (11–17) 13 (11–17) 13 (11–17)
PELOD score (range) 11(1–11) 6 (1–11) 11 (1–11)
WI score: n (range) 38 (22–54)
a 3 (0–28) 30 (0–45)
Operative course
CPB time: min (range) 78 (55–126) 64 (44–117) 73 (50–120)
Aortic crossclamp time: min (range) 50 (37–90) 39 (25–83) 45 (34–86)
Hypothermia: C (range) 30.0 (28.7–31.7) 32.4 (29.8–34.1) 31.0 (28.8–33.0)
Postoperative course
Glucose intake: mg/kg/min (range)
b 3.5 (1.8–7.4) 3.3 (1.0–6.2) 3.4 (1.8–6.5)
Ventilation duration: h (range) 11 (7–25) 7 (6–11) 9 (6–17)
Inotropes: n (%) 24 (75) 6 (35) 30 (61)
Length of ICU stay: days (range) 2 (2–2) 2 (2–2) 2 (2–2)
Length of hospital stay: days (range 7 (7–9) 7 (7–8) 7 (7–8)
Data are expressed as median (interquartile range) or numbers (percentage)
RACHS risk adjustment for congenital heart surgery, PRISM score pediatric risk of mortality score, PELOD score pediatric logistic organ
dysfunction score, WI score weighted inotropic score based on maximum inotropic support during surgery and ICU stay, CPB cardiopulmonary
bypass, ICU intensive care unit
a Denotes signiﬁcant difference between patients treated with and without glucocorticoids, P\0.05
b Glucose intake started at ICU admission
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123cortisol–ACTH ratios in the children treated with glucoc-
oricoids (Fig. 1d). At 12 and 24 h after surgery, the cortisol
levels and cortisol–ACTH ratios of the children with glu-
cocorticoid treatment had spontaneously decreased to the
levels in the children without glucocorticoid treatment. In
both groups, however, the cortisol levels still were higher
than the levels at the start of surgery. The IL-6 level 12 and
24 h after surgery was signiﬁcantly lower in the children
treated with glucocorticoids. The IL-10 level at the end of
surgery and 12 h after surgery was signiﬁcantly higher in
the children treated with glucocorticoids. There were no
other differences in laboratory parameters between the two
groups.
Discussion
Our study showed that treatment with glucocorticoids
during surgery was the main factor associated with the
occurrence of hyperglycemia at the end of CPB surgery for
congenital heart defects. Hyperglycemia frequently occur-
red with the highest blood glucose levels at the end of
surgery and disappeared spontaneously (without insulin
therapy) within 12–24 h in the majority of the children
without signiﬁcant postoperative morbidity.
The occurrence of hyperglycemia was not associated
with increased morbidity, as shown by duration of venti-
lation, ICU stay, or hospital stay. Moreover, the overall
morbidity in our population was low. The median duration
of mechanical ventilation was 9 h, whereas the ICU say
was 2 days and the hospital stay was 7 days. Renal dialysis
and extracorporeal life support did not occur, and all the
patients survived.
Hyperglycemia in critically ill children is caused by
multiple proposed mechanisms including counterregulatory
hormone-mediated upregulation of gluconeogenesis and
glycogenolysis and downregulation of glucose transporters
with decreased peripheral use of glucose by tissues such as
skeletal muscle and liver [29].
In the current study, we evaluated how many hyper-
glycemic patients showed signs of insulin resistance
because this is described as the main factor causing
hyperglycemia in critically ill adults [23, 26, 36]. In only
four children (9%) was an increased insulin–glucose ratio
([18 pmol/mmol) seen at the end of surgery. The
remaining hyperglycemic children showed a normal or
(relatively) decreased insulin–glucose ratio. The plasma
insulin levels increased 24 h after surgery, which might
have been due to the fact that most patients were detubated
and already receiving enteral nutrition. The increase in
insulin levels can be interpreted as a recovery response to
the administered enteral feeding.
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123The decreased insulin response after surgery might be
due to the fact that critically ill children seem to be more
vulnerable than adults to beta-cell dysfunction. Preissig and
Rigby [20] hypothesized that beta cells, known to be
exquisitely sensitive to rapid physiologic changes, may
become dysfunctional if these changes occur acutely above
a certain threshold. These changes may be induced by
multiple factors such as hypothermia, vasopressors, ele-
vations of proinﬂammatory cytokines, and use of gluco-
corticoids [1, 9, 12, 20].
In the study by Preissig and Rigby [20], the vasopressor
score of critically ill children with respiratory and cardio-
vascular failure was inversely correlated with the C-peptide
level, indicating beta-cell dysfunction due to the sup-
pressing effect of exogeneous catecholamines. In our study,
the use of vasopressors was low, with only one patient
receiving noradrenalin. This may explain the relatively
normal plasma insulin levels at the end of surgery.
Another explanation for the less pronounced hypoinsu-
linemic response in our study might be the mild effect of
cardiac surgery on the inﬂammatory response, as shown by
the low levels of Il-6 and the mildly increased IL-10 at the
end of surgery in the patients without glucocorticoid
treatment. Perioperative administration of glucocorticoids
was associated with decreased IL-6 and increased IL-10
levels after CPB. This accords with adult studies showing
that glucocorticoids may decrease the inﬂammatory
response during the CPB procedure [3]. However, for
pediatric patients with congenital heart disease undergoing
CPB surgery, the clinical beneﬁt of this suppressed cyto-
kine response remains unclear.
Debate exists about the positive effects of steroid use
during CPB in pediatric patients and whether the potential
positive effects of corticosteroid treatment during CPB
surgery outweigh the potential adverse effects, such as
hyperglycemia [4, 22]. High blood glucose levels at the end
of CPB surgery for congenital heart defects also were
found in previous studies [1, 7, 21, 24]. We found a
spontaneous normalization of blood glucose levels within
24 h postoperatively, which is in line with the ﬁnding of
one other study [24]. However, a few other studies show a
more gradual decrease in blood glucose levels over 3 days
[18, 35]. This could be related to our relatively low post-
operative morbidity compared with other studies and
comparable preoperative illness severity as expressed by
RACHS.
Fig. 1 Time course of blood levels of glucose (a), insulin (b),
insulin–glucose ratios (c), and cortisol (d) at the start of surgery, at the
end of surgery, and 12 and 24 h after surgery for patients treated with
and those treated without glucocorticoids. Box–whisker plots: the
boxes indicate the 25th to the 75th percentiles with the median, and
the attached whiskers indicate the complete range with the exclusion
of outliers (open circle) and extremes (*)
c
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123Other authors [21] have reported an increase in ICU stay
(median, 3–6 days), mechanical ventilation (4.4 days),
dialysis (1.1–4%), extracorporeal life support (3–8%), and
mortality (4–11%). Vlasselaers et al. [31] reported their
results from a prospective randomized controlled trial of
treatment for critically ill children (75% were patients after
cardiac surgery for congenital heart defects). Intensive
insulin therapy for hyperglycemia improved morbidity and
reduced mortality, but the harm of insulin-induced hypo-
glycemic events is debated [11]. It is important to realize
that not only hyperglycemia but also hypoglycemia is
associated with an adverse outcome [7, 25, 34, 35].
In general, important differences exist between centers
in terms of morbidity and mortality after pediatric cardiac
surgery. In our study, none of the patients were treated with
insulin for hyperglycemia, and overall morbidity was low,
so the standard use intensive insulin therapy is not needed
for tight glycemic control.
A limitation of this study was that glucocorticoids were
administered at the discretion of the attending anesthetist.
Although treatment was not randomized, glucocorticoids
were administered before aortic clamping and thus were
independent of the operative course. Moreover, there were
no differences in age, clinical course, or duration of CPB
time between the patients with and those without gluco-
corticoid treatment. Furthermore, although the patients
with cyanotic heart disease were more likely to receive
glucocorticoids and although the median WI score was
higher for the glucocorticoid-treated patients, univariate
analysis of variance showed that preoperatively adminis-
tered glucocorticoids were independently associated with
increased blood glucose levels at the end of surgery.
In summary, our study showed that the development of
hyperglycemia at the end of cardiac surgery for congenital
heart disease was associated with glucocorticoid adminis-
tration during surgery. Postoperative hyperglycemia was
frequent, but in almost all cases (94%), blood glucose
levels spontaneously normalized within 24 h without the
use of insulin administration and without signiﬁcant mor-
bidity or mortality. The standard use of intensive insulin
therapy for tight glycemic control is not needed in this
patient group. In contrast to our hypothesis, we conclude
that because postoperative morbidity was low in the study
group, the presumed positive effects of glucocorticoids
seemed to outweigh the adverse effects of iatrogenic
hyperglycemia.
Future research should focus on the value of glucocor-
ticoid therapy during pediatric cardiac surgery, weighing
both the pros and cons of either hyperglycemia or gluco-
corticoid therapy.
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